Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2013-03-13
Original SEC Filing: Click here

---

Webplus: CBPO/20130313/8-K/2_EX-99.1/000.htm SEC Original: exhibit99-1.htm
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012 FY12 Total Sales Up 20.7% to $184.8 Million FY12 Operating Margin Reaching 40.3% FY12 Non-GAAP Net Income Up 31.5% to $48.0 Million BEIJING, March 13, 2013 /PRNewswire-FirstCall/ — China Biologic Products, Inc. (NASDAQ: CBPO, “China Biologic” or the “Company”), a leading fully integrated plasma-based biopharmaceutical company in

---

---

Webplus: CBPO/20130313/8-K/1/000.htm SEC Original: form8k.htm
FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6698-3166 (Former name or former address,

---

Company Information:

Ticker: CBPO, Company: China Biologic Products, Inc., Type: 8-K, Date: 2013-03-13CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING
BEIJING 100125